Wooree Bio우리바이오
082850 · KOSDAQ · ₩082850 · 우리바이오
₩4,135▼ ₩180 (4.17%)End-of-day · Oct 29, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 9.3% | 9.1% | 9.6% | 9.2% | 8.5% | 7.5% |
| Operating margin | −0.4% | 0.1% | 1.2% | 2.1% | 2.5% | 2.8% |
| Net margin | 0.3% | −0.9% | 0.4% | 1.2% | 1.6% | 2.1% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +5.4% | −15.6% | −2.1% | −6.7% | −12.2% | — |
| Operating income growth | −542.6% | −93.7% | −41.5% | −24.4% | −19.7% | — |
| Net income growth | +137.3% | −297.6% | −69.6% | −28.6% | −34.2% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 1.7% | −4.5% | 2.3% | 8.2% | 13.1% | 21.4% |
| Return on assets | −0.3% | −1.5% | 1.4% | 3.3% | 4.1% | 6.6% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 231.6% | 191.5% | 126.5% | 133.2% | 146.5% | 233.1% |
| Net debt to equity | 2.8% | 3.7% | 12.8% | 1.5% | 8.0% | 5.0% |
| Current ratio | 115.2% | 126.0% | 144.3% | 142.7% | 135.7% | 117.3% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Wooree Bio / 우리바이오 / 082850 / KRX:082850
Source: KRX statistical information